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BACKGROUND Optimal lead positioning is an important determi-
nant of cardiac resynchronization therapy (CRT) response.
OBJECTIVE The purpose of this study was to evaluate cardiac
computed tomography (CT) selection of the optimal epicardial
vein for left ventricular (LV) lead placement by targeting regions
of late mechanical activation and avoiding myocardial scar.
METHODS Eighteen patients undergoing CRT upgrade with existing
pacing systems underwent preimplant electrocardiogram-gated car-
diac CT to assess wall thickness, hypoperfusion, late mechanical acti-
vation, and regions of myocardial scar by the derivation of the stretch
quantiﬁer for endocardial engraved zones (SQUEEZ) algorithm. Car-
diac venous anatomy was mapped to individualized American Heart
Association (AHA) bull’s-eye plots to identify the optimal venous
target and compared with acute hemodynamic response (AHR) in
each coronary venous target using an LV pressure wire.
RESULTS Fifteen data sets were evaluable. CT-SQUEEZ–derived
targets produced a similar mean AHR compared with the best
achievable AHR (20.4% 6 13.7% vs 24.9% 6 11.1%; P 5 .36).
SQUEEZ-derived guidance produced a positive AHR in 92% of target
segments, and pacing in a CT-SQUEEZ target vein produced a greater
clinical response rate vs nontarget segments (90% vs 60%).
CONCLUSION Preprocedural CT-SQUEEZ–derived target selection
may be a valuable tool to predict the optimal venous site for LV
lead placement in patients undergoing CRT upgrade.
KEYWORDS Cardiac computed tomography; Cardiac resynchronization
therapy; CT guided intervention; Dyssynchrony; Myocardial ﬁbrosis
(Heart Rhythm 2017;14:1364–1372) © 2017 The Authors. Pub-
lished by Elsevier Inc. on behalf of Heart Rhythm Society. This is
an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).
Introduction
Patients with existing pacing systems, left ventricular (LV)
systolic impairment, and a high proportion of right ventricu-
lar (RV) pacing beneﬁt from cardiac resynchronization ther-
apy (CRT).1 CRT nonresponse occurs because of suboptimal
LV lead positioning in myocardial scar with persistent
dyssynchrony.2,3 Cardiac magnetic resonance (CMR) can
guide LV lead placement by avoiding scar and targeting
late mechanical activation (LMA)4; however, 28% of
patients undergoing CRT have existing pacing systems
unsuitable for CMR.5 Cardiac computed tomography (CT)
has the potential to guide LV lead placement in patients
with existing pacing systems.6 Rapid acquisition of
3-dimensional, isotropic, whole heart data sets with submilli-
meter spatial resolution can accurately delineate the coronary
venous tree,7 noninvasively assess regional and global LV
function,8 and detect regional hypoperfusion/myocardial
scar.9 Recently, CT has evaluated regional and global LV
dyssynchrony and areas of LMA by calculating the stretch
of the endocardial surface throughout the cardiac cycle
(stretch quantiﬁer for endocardial engraved zones
[SQUEEZ]).10 In patients with existing pacing systems un-
dergoing CRT, we hypothesized that preprocedural cardiac
Dr Claridge has received research funding from Abbott. Dr Jackson and
Dr Sieniewicz have received research funding from Medtronic. Dr Rinaldi
has received research funding from Abbott and Medtronic. Dr McVeigh
owns founder’s shares in MRI Interventions. Address reprint requests
and correspondence: Dr Jonathan M. Behar, Division of Imaging Sciences
& Biomedical Engineering, 4th Floor, LambethWing, St. Thomas’Hospital,
Westminster Bridge Rd, London SE1 7EH, United Kingdom.
E-mail address: jonathan.behar@kcl.ac.uk.
1547-5271/© 2017 The Authors. Published by Elsevier Inc. on behalf of Heart Rhythm Society.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/
4.0/).
http://dx.doi.org/10.1016/j.hrthm.2017.04.041
CT-SQUEEZ by targeting areas of LMA and avoiding
myocardial scar could guide LV lead placement through
identiﬁcation of the optimal venous target.
Methods
The study complied with the Declaration of Helsinki, and the
protocol was approved by the local ethics committee.
Informed consent was obtained from each patient. Between
September 2014 and July 2016, we prospectively recruited
18 patients with a preexisting pacemaker/implantable
cardioverter-deﬁbrillator, persistent heart failure symptoms
on optimal medical therapy, LV ejection fraction ,45%,
and .50% RV pacing.
Preassessment
Patients underwent clinical assessment (New York Heart
Association score and Minnesota Living with Heart Failure
questionnaire), 6-minute walk test, cardiopulmonary exercise
test, and 2-dimensional transthoracic echocardiography.
Ischemic cardiomyopathy (ICM) was deﬁned by prior
myocardial infarction, coronary angiography demonstrating
severe coronary disease and subsequent revascularization,
and/or CMR evidence of myocardial ﬁbrosis. Absence of
these features inferred non-ICM.
Cardiac CT
Patients underwent cardiac CT using the Brilliance iCT
256-slice MDCT scanner (Philips Healthcare, Best, The
Netherlands) before upgrade. Intravenous metoprolol was
used to achieve a heart rate of,65 beats/min in sinus rhythm
and ,100 beats/min in atrial ﬁbrillation. A total of 120 mL
of intravenous contrast (Omnipaque, GE Healthcare, Prince-
ton, NJ) was injected (5 mL/s) via a power injector into the
antecubital vein. Descending aorta contrast-triggered (180
Hounsﬁeld units [HU]), electrocardiogram (ECG)–gated
scanning was performed with single breath-hold technique
after a 10- to 12-second delay. Scanning parameters
included a heart rate–dependent pitch of 0.2–0.45, a gantry
rotation time of 270 ms, a tube voltage of 100 or 120 kVp
depending on the patient’s body mass index, and a tube cur-
rent of 125–300 mA depending on the thoracic circumfer-
ence. A second single-phase ECG-gated scan was acquired
12 minutes after the initial contrast bolus for myocardial
scar imaging; the tube voltage was reduced by 20 kVp while
the tube current was increased proportionally to account for
an increase in image noise.11 Initial retrospective ECG-gated
scans were reconstructed in 10% phase increments
throughout the cardiac cycle using iterative reconstruction,
with 1-mm slice thickness, 0.5-mm slice increment, 250-
mm ﬁeld of view, 512 ! 512 matrix, and an Xres smooth
reconstruction kernel. Iterative reconstruction using the
iDose4 algorithm (range 1–7) was used to reduce image
noise and radiation dose. The cardiac CT scan was evaluated
by an independent Society of Cardiovascular Computed
Tomography Level III cardiac CT expert (R.R.). First-pass
contrast-enhanced sequences were analyzed using
standardized multiplanar reconstruction windows according
to the AHA nomenclature for regional segmentation.
End-diastolic myocardial wall thickness was evaluated
reviewing each myocardial region in both short- and
long-axis views. Areas of hypoperfusion were evaluated
systematically with slice width thickness increased to
5 mm and display window and level settings adjusted to
100 and 200 HU, respectively. Abnormal perfusion was
deﬁned as myocardium exhibiting signiﬁcantly reduced
contrast distribution visually compared against attenuation
of normal myocardium in each patient used as an internal
reference. Where discrepancies existed, a 50 HU difference
between normal and hypoperfused myocardium was
used12,13 along with consensus opinion from 2 individual
experts in cardiac CT (AHA/ACC Level III experience,
blinded to the clinical data).
We adopted a pragmatic approach for identifying regions
of delayed enhancement as previously described.11 This
qualitative identiﬁcation of scar where the myocardium is
brighter reﬂects the current lack of standard criteria in the
literature mainly because the Hounsﬁeld unit attenuation
varies signiﬁcantly between patients with no accepted value
set as a cutoff for ﬁbrosis. Where scar detection was difﬁcult,
surrogate markers of a wall thickness of,6 mm and regional
hypoperfusion were used to infer scar.
CT-derived SQUEEZ
High-contrast disparity between LV blood pool and myocar-
dium permits the identiﬁcation and tracking of ﬁnely
engraved endocardial surface features. The SQUEEZmethod
uses these features to track endocardial material points over
the heart cycle to calculate regional cardiac function using
the following formula:
SQUEEZðv; tÞz
ﬃﬃﬃﬃ
A
p ðv; tÞ
ﬃﬃﬃﬃ
A
p ðv; 0Þ
where A(v, 0) is the area of the small triangular patch (v) on
the endocardial mesh at end diastole and A(v, t) is the area of
the same patch at time t. The SQUEEZ metric is calculated
for each of the triangular patches across the endocardium
through cardiac phases. Thus, a high-resolution regional
map of endocardial strain can be computed as SQUEEZ 2
1 at each point (Figure 1). This metric has been correlated
with circumferential strain (Ecc), the criterion standard for
noninvasive regional strain, using tagged CMR sequences
in a canine model of myocardial infarction.14
SQUEEZ-derived regional function data were merged
with individual patient anatomy. Septal segments were
excluded as targets. SQUEEZ-derived strain curves with
low amplitude strain (LAS) ,10% shortening were judged
nonviable and excluded as targets (analogous to echocardio-
graphic data with poor CRT response with LV lead place-
ment in segments with LAS ,9.8%).11,12 Regional time to
peak strain (minimal SQUEEZ value) was calculated using
the individual heart rate/cycle length for the CT acquisition
(Figure 2). Given the distribution of the coronary veins, the
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Figure 1 A: Computed tomography mid-ventricular short-axis images of the left ventricle at 2 time points in the R-R interval (0%5 end diastole; 50%5 end
systole). Anterior and anteroseptal regions are akinetic and seen not to move throughout the cardiac cycle compared with the inferolateral segments that move
inward by end systole. Inevitable beam hardening artifact from the existing pacing system noted in the right ventricle. B: Stretch quantiﬁer for endocardial
engraved zones values (y axis) vs cardiac cycle length (%) across 16 AHA segments demonstrate akinetic regions (red box) and late activating inferior/infero-
lateral walls (green box representing an ideal target for left ventricular lead placement).
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time to peak strain of myocardial segments overlying the
same coronary vein was averaged to produce anterior, lateral,
and inferior values for mechanical activation delay and
compared with hemodynamic data.
CRT implantation
CRT upgrade was performed with a quadripolar LV lead in
17 patients (94%) and a bipolar lead in 1 because of unfavor-
able venous anatomy. Nine patients (50%) received CRT
with deﬁbrillator; 1 patient required an additional RV shock
lead; and the remaining 8 already having preexisting implant-
able cardioverter-deﬁbrillators. Identiﬁcation of the optimal
hemodynamic site for LV stimulation was performed by
measuring acute hemodynamic response (AHR) using an
0.014-in high-ﬁdelity Certus RADI PressureWire (St. Jude
Medical, St. Paul, MN) in the LV cavity via a retrograde
arterial approach as previously described.13 Atrial pacing
10 beats/min above the intrinsic rate or RV pacing (DDDRV)
for patients with no underlying rhythm was baseline.
Atrioventricular delays were ﬁxed at 100 ms and ventriculo-
ventricular delay at 0 ms. AHR for each venous site
compared biventricular pacing with baseline (% change,
dP/dtmax, mm Hg/s). AHR was compared with CT indices
and the sensed QLV interval at each pacing site.14 Patients
underwent 6-month follow-up to identify clinical responders
via the Packer score15 and echocardiographic response
deﬁned as reduction in LV end-systolic volume .15%.
The primary end point was cardiac CT–derived regional
endocardial strain analysis (SQUEEZ) prediction of the
pacing site achieving the optimal AHR.
Statistics
Continuous data were presented as mean 6 SD. Those with
Gaussian distribution were compared using a paired t test;
Figure 2 A: Bull’s-eye plot of the time delay (color scale, in milliseconds) until 10% shortening occurs (ie, time for SQUEEZ value to reduce from 1.0 to 0.9)
across left ventricular regions. Dark red/brown shows anterior and anteroseptal segments not achieving 10% shortening and likely represents infarcted myocar-
dium. The outlined red box represents areas to avoid (akinetic segments). Red-colored regions in the inferolateral wall show the latest activation away from areas
of scar; the outlined green box shows the target pacing regions.B:Bull’s-eye plot with color scale representing SQUEEZ values. All segments begin at a SQUEEZ
value of 1. Yellow represents a SQUEEZ value of .1 (paradoxical stretch/dyskinesis in septal regions). Blue represents a SQUEEZ value of ,0.8, and viable
regions with reasonable shortening deemed as good targets. SQUEEZ 5 stretch quantiﬁer for endocardial engraved zones.
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those with a non-Gaussian distribution were compared using
the Wilcoxon matched-pair signed rank test. Categorical data
were presented as absolute number of occurrences and
associated frequency (%). Analysis of variance was used to
compare .2 groups. The results were considered signiﬁcant
at a P value of ,.05.
Results
The patient demographic characteristics are summarized in
Table 1. Patients had a high percentage of RV pacing with
a mean QRS duration of 173 6 21 ms. Eight patients
(44%) had ICM.
Quality of CT data sets
All CT scans were successfully completed (mean heart rate
64 6 7 beats/min; mean radiation dose-area product 1194
6 419 mGy$cm2). Patients were supine for 15 6 1 minutes.
Studies were independently assessed using the Society of
Cardiovascular Computed Tomography quality score16
(mean score 3.46 1.3 out of 5). The main reason for reduced
scoring was beam hardening artifact from existing pacing
wires. Wall thinning/hypoperfusion (inferring scar) was
present in 7 of 8 patients with ICM; however, late contrast
enhancement was limited to 1 patient.
CT-SQUEEZ–derived target segments to predict the
optimal venous target
Eighteen patients underwent successful LV lead implantation,
and 15 of 18 had full hemodynamic and CT data sets. In 1 pa-
tient a RADI wire was not sited because of arterial access, and
2 patients had CT scans of insufﬁcient quality for analysis.
CT-SQUEEZ analysis identifying the target epicardial vein
subtending the area of LMA excluding LAS regions (inferring
scar) was compared with all sites where AHR was measured
(3 6 1 coronary veins per patient). AHR (mean % change)
was as follows: 2.5%6 8.8%, anterior; 14.5%6 11.5%, ante-
rolateral; 23.2%6 7.7%, lateral; 21.8%6 15.0%, posterolat-
eral; and 12.4% 6 5.1%, posterior (analysis of variance,
P 5 .001). Lateral and posterolateral veins produced the
best AHR irrespective of etiology. The lateral vein stimulation
produced greater AHR than did the anterior vein (23.2%
6 8.8% vs 2.5% 6 8.8%; P , .001) (Figure 3). Notably
2 of 15 patients (13%) had no epicardial vein supplying the
CT target. In the remaining 13, the CT-SQUEEZ target deter-
mined LV implantation site, achieving maximal AHR in
9 (70%). A .10% increase in dP/dtmax (positive AHR)
13
was achieved in 22% anterior, 50% anterolateral, 100% lateral,
80% posterolateral, and 67% posterior sites tested. AHR
.10%was achieved in 12 of 13 patients (92%) with an epicar-
dial vein supplying a CT-SQUEEZ target (the remaining
patient had a target AHR of 6.8%).
CT vs hemodynamic/electrical guidance (Figure 4)
CT-SQUEEZ targets produced AHR similar to the best achiev-
able AHR (20.4% 6 13.7% vs 24.9% 6 11.1%; P 5 .36).
Targeting electrical latency (longest QLV interval) achieved
a similar AHR (19.4% 6 11.5%; P 5 .85). Pacing scar
produced the lowest AHR (6.8%6 3.2%;P5 .04 vsCT) com-
parable to the worst achievable AHR (6.4%6 3.1%; P5 .01
vs CT). AHR and QLV interval weakly correlated in 63 paired
data sets (Pearson r 5 0.31; P 5 .01). The AHR of locations
with QLV interval.100ms but in scar was signiﬁcantly lower
than that of nonscarred locations (5.2% 6 1.5% vs 19.5%
6 9.4%; P 5 .005) (Figure 5).
CRT response (Table 2)
At 6 months, patients symptomatically improved (New York
Heart Association 1.76 0.7 vs 2.86 0.4; P, .001 and Min-
nesota Living with Heart Failure questionnaire scores 32
6 24 vs 396 19; P5 .03) and were able to walk on average
92 m further over 6 minutes. The paced QRS duration was
shorter (1426 18ms vs 1736 21ms; P, .001), LV ejection
fraction increased (34% 6 10% to 44% 6 15%; P 5 .001),
and N-terminal pro-brain natriuretic peptide level decreased
(472 6 459 vs 1121 6 749; P 5 .003). Patients paced in
CT-SQUEEZ targets had greater clinical response than did
those paced in nontarget segments (90% vs 60%;
P , .001) (Figure 6). Hundred percent of patients with
non-ICM were clinical and echocardiographic responders
as compared with only 63% of patients with ICM (P 5 .07).
Discussion
The principal ﬁndings were as follows:
1. CT-SQUEEZ targets produced a mean AHR similar to the
best achievable AHR (20.4% 6 13.7% vs 24.9%
6 11.1%; P 5 .36).
2. CT-SQUEEZ guidance produced positive AHR in 92% of
cases when a target segment was paced.
3. Pacing a CT-SQUEEZ target vein produced greater
clinical response vs nontarget segments (90% vs 60%).
We demonstrate the novel utility of preprocedural CT for
LV lead guidance to regions of LMA devoid of LAS.
Figures 1 and 2 show that cardiac CT sequences were able
to generate functional data sets with sufﬁcient temporal reso-
lution to differentiate the region of LMA. In addition to wall
Table 1 Demographic characteristics
Characteristic Value
Age (y) 68.8 6 15.5
Sex: male 14 (78)
Ischemic cardiomyopathy 8 (44)
RV pacing (%) pre-CRT 92.2 6 17
LBBB 15 (83)
QRS duration (ms) 173 6 21
Sinus rhythm 16 (89)
LV end-diastolic volume (mL) 186 6 65
LV end-systolic volume (mL) 128 6 62
LV ejection fraction (%) 34 6 10
Values are presented as mean 6 SD or as n (%).
CRT 5 cardiac resynchronization therapy; LBBB 5 left bundle branch
block; LV 5 left ventricular; RV 5 right ventricular.
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thinning and hypoperfusion, the SQUEEZ algorithm inferred
regions of scar on the basis of LAS in keeping with echocar-
diographic studies (deﬁned LAS as radial strain ,10%), re-
sulting in suboptimal response to CRT.15 Our CT protocol
included a late enhancement sequence to identify ﬁbrosis;
however, we identiﬁed only late enhancement in 1 patient.
Our CT-SQUEEZ–derived algorithm predicted regions
with an AHR within 2.5% of the maximum in 11 of 12 cases
(92%). In addition, patients paced in CT targets had a more
favorable response (Figure 4). In 1 case, the mismatch
between the CT target and the vein with the best AHR was
signiﬁcant (22.2%). In 2 cases, CT-SQUEEZ targeted the
posterior wall; however, the patients had no epicardial vein
overlying this site.
The clinical utility of AHR .10% in predicting CRT
response has been demonstrated,16 and using this cutoff, a
high proportion of CT targets had a positive AHR. There
was a trend toward greater AHR in sites out of scar vs CT
inferred scar (14.8% 6 12% vs 6.8% 6 8%; P 5 .17). The
mean AHR was similar in CT targets compared with the
QLV interval (Figure 4), reﬂecting a correlation between
electrical and mechanical dyssynchrony. However, regions
with electrical latency (QLV interval .100 ms) in scar re-
sulted in suboptimal AHR, suggesting that the QLV interval
alone may fail to identify the optimal stimulation site in the
presence of scar.
Figure 3 Left:Occlusive venography with nomenclature for the coronary venous tree. Reproduced with permission from Spencer et al.17 Right:Regional acute
hemodynamic response by coronary vein tested. Box-and-whisker plot for each vein detailing the mean (solid line), range, and SD. Acute hemodynamic response
values are % change in dP/dt vs baseline. There was a signiﬁcant difference between groups: P5 .001 (ANOVA). AIV5 anterior interventricular vein; ANOVA
5 analysis of variance; CS 5 coronary sinus; LAO 5 left anterior oblique; MCV 5 middle cardiac vein.
Figure 4 Percentage change AHR determined by pacing the vein with
optimal AHR per patient (Best, n 5 14), the CT-SQUEEZ–derived target
(CT target, n 5 12), greatest electrical latency (Longest QLV, n 5 13),
absence of scar (Out of scar, n 5 14), presence of scar (In scar, n 5 6),
and the vein with the worst AHR per patient (Worst, n 5 14). Best vs CT
target, P 5 .36; Best vs Longest QLV, P 5 .22; Best vs Out of scar,
P 5 .03; Best vs In scar, P 5 .002; Best vs Worst, P 5 .0002; CT target
vs Longest QLV, P 5 .85; CT target vs Out of scar, P 5 .29; CT target vs
In scar, P5 .04; CT target vs Worst, P5 .009. AHR5 acute hemodynamic
response; CT 5 computed tomography; SQUEEZ 5 stretch quantiﬁer for
endocardial engraved zones.
Figure 5 Scatterplot of AHR vs QLV interval. Each patient had multiple
data points acquired. There is a weak correlation between AHR and QLV in-
terval (r5 0.31; P5 .01). Locations in scar (red) had a lower AHR than did
locations out of scar (blue). AHR 5 acute hemodynamic response.
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We previously demonstrated that CMR-derived scar and
dyssynchrony can guide LV lead implantation18 with excel-
lent CRT response if pacing in a CMR target in keeping with
the present ﬁndings. Similarly, Laksman et al19 used CMR-
derived scar and dyssynchrony-guided lead placement with
echocardiographic super-response in 58% of patients.
Currently there are limited clinical data describing the use
of cardiac CT LV lead guidance.20 Two randomized
controlled studies TARGET21 and STARTER22 have shown
beneﬁt with LV lead guidance using speckle tracking echo-
cardiography.
Scar avoidance using CMR-derived late gadolinium
enhancement is associated with improved cardiovascular
outcomes.23 The ability of CMR to accurately deﬁne scar is
superior to CT; however, almost one-third of patients under-
going CRT have existing pacemakers unsuitable for CMR.5
Cardiac CT offers several potential advantages over CMR.
Images of superior spatial resolution within a
3-dimensional isotropic data set are acquired within a matter
of seconds; the new generation of CT scanners produce
images in a single heartbeat. In addition, an exquisite differ-
entiation of endocardium and blood pool enables accurate
tracking of regional surfaces over the duration of the cardiac
cycle. Delayed triggered contrast-enhanced sequences facili-
tate good opaciﬁcation of the coronary venous tree, and
volume-rendered reconstructions can delineate the course
of potential venous targets before implantation. This may
be particularly advantageous as coronary venous anatomy
is highly variable and may impact successful CRT delivery.24
Furthermore, identiﬁcation of coronary sinus valves and
highly angulated/tortuous vessels may help in patients with
a previously failed implant. While targeting regions of
Table 2 CRT response
Variable Preassessment 6-mo follow-up P
NYHA class symptoms 2.8 6 0.4 1.7 6 0.7 ,.001
MLHF questionnaire points 39 6 19 32 6 24 .03
6-minute walking distance (m) 291 6 137 383 6 154 .06
Paced QRS duration (ms) 173 6 21 142 6 18 ,.001
CPET, VO2max (mL/(min$kg)) 17.9 6 4 18.1 6 5 .84
CPET, slope @ VO2max 36 6 9 34 6 5 .88
LV end-diastolic volume (mL) 186 6 65 154 6 61 .01
LV end-systolic volume (mL) 128 6 62 93 6 60 .01
2D LVEF (TTE) (%) 34 6 10 44 6 15 .001
NT-pro-BNP level 1121 6 749 472 6 459 .003
Values are presented as mean 6 SD.
2D5 2-dimensional; CPET5 cardiopulmonary exercise test; CRT5 cardiac resynchronization therapy; LV5 left ventricular; LVEF5 left ventricular ejection
fraction; MLHF 5 Minnesota Living with Heart Failure questionnaire; NT-pro-BNP 5 N-terminal pro-brain natriuretic peptide; NYHA 5 New York Heart Associ-
ation; TTE 5 transthoracic echocardiogram; VO2max 5 maximum oxygen consumption.
Figure 6 Clinical response rates in CT-SQUEEZ target (n 5 10) vs nontarget (n 5 5) (P , .001) and ICM (n 5 8) vs NICM (n 5 10) (P 5 .07). CT 5
computed tomography; ICM5 ischemic cardiomyopathy; NICM5 nonischemic cardiomyopathy; SQUEEZ5 stretch quantiﬁer for endocardial engraved zones.
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LMA is scientiﬁcally sound, LV lead placement is restricted
by coronary vein anatomy that may not always overly the
optimal region. In a cardiac CT study of 121 postmortem
hearts, 29% had no coronary vein overlying the posterolateral
region.17 Lack of a venous target identiﬁed by preprocedural
CT may allow alternative forms of LV stimulation (multisite/
endocardial) to be considered.25,26
Study limitations
Modern single energy source CT scanners are currently
unable to accurately delineate extracellular myocardial
ﬁbrosis through late contrast enhancement. While iodinated
contrast displays similar kinetic properties to gadolinium-
DTPA (diethylenetriamine penta-acetic acid) and can demon-
strate acute hypoperfusion from ischemic injury, reliable
visualization of chronic ﬁbrosis with late enhancement
occurred in only 1 patient. We therefore used local wall thin-
ning (,6mm) and/or hypoperfusion to infer scar, and the low
AHR in these segments is in keepingwith scar despite the lack
of visualization (Figures 4 and 5). The presence of existing
pacing systems resulting in beam hardening artifact and
degradation of signal in myocardial tissue local to the pacing
leadsmay explain this. One study reporting a good correlation
between late enhancement and scar in histological macro-
scopy in a chronic porcine mode25 used higher-contrast doses
than our study (1456 35 mL vs 1206 0 mL; P5 .005), and
the animals had no preexisting pacing systems. The develop-
ment of dual energy source CT scanners holds promise in
improving differentiation between subtle soft tissue charac-
teristics and may be able to more reliably demonstrate
myocardial ﬁbrosis.27 The temporal resolution of cardiac
CT in this study (70–100 ms) is inferior to echocardiography
(20 ms) and CMR (35–50 ms, obtained over multiple beats),
and cardiac CTmay be less sensitive to subtle regionalmotion
changes.While the SQUEEZ algorithmdetectsmotion abnor-
malities with high resolution, only lower-resolution estimates
(16 standard AHA segments) were needed. Furthermore, the
CT-SQUEEZ–derived metric has been shown to correlate
well with circumferential strain (Ecc) in an animal model, sug-
gesting that it is sensitive enough to demonstrate local
regional motion differences and remain a useful tool to assess
dyssynchrony.14 The utility of AHR in predicting CRT
response16 is limited, and the results of a largemulticenter ran-
domized trial of AHR are awaited (RADI-CRT, Clinical Trial
Registration No.: NCT01464502).
Conclusion
Preprocedural CT-SQUEEZ–derived target selection may be
a valuable tool to predict the optimal venous site for LV lead
placement by guiding the implanter toward late activating
regions, away from areas of scar.
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